Get Fit Bharat

Tag: HIIT

HomeHIIT

TOKYO, Japan:  Rigaku Corporation, a Rigaku Holdings Group company that serves as a global solution partner for X-ray analytical equipment (headquarters: Akishima, Tokyo; CEO: Jun Kawakami; “Rigaku”), opened Rigaku BioScience Lab in Cambridge, Massachusetts, USA.   This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241121012183/en/   Ribbon …

Sydney, Australia:  Boomi™, the intelligent integration and automation leader, today announced that Australian precious metals and jewellery company Pallion Group has bolstered resilience and customer experience (CX) across its brands, and laid a foundation for generative AI using the Boomi Enterprise Platform as the baseline for its data strategy.   …

Indian food is renowned for its diversity. It offers a variety of dishes, from dals and vegetables to rotis. Roti holds a significant place in the Indian thali, with wheat roti being the most commonly served in Indian homes. While ragi and multigrain rotis have gained popularity, certain rotis are prepared seasonally, such as maize, …

ALISA BANK PLC MANAGER TRANSACTIONS 21.11.2024 AT 16.30 EET Person subject to the notification requirementName: Wallenius, ChristinaPosition: Other senior managerIssuer: Alisa Bank PlcLEI: 743700VK1NB8HRGTQH74 Notification type: INITIAL NOTIFICATIONReference number: 743700VK1NB8HRGTQH74_20241121111540_20 Transaction date: 2024-11-21Venue not applicableInstrument type: SHAREISIN: FI4000170915Nature of the transaction: SUBSCRIPTION Transaction details(1): Volume: 120482 Unit price: 0.166 EUR …

Max Verstappen played down his prospects of clinching a fourth consecutive drivers' world championship at this weekend's Las Vegas Grand Prix. The Red Bull driver, who claimed a spectacular victory in the rain-hit Sao Paulo Grand Prix three weeks ago, said that triumph had not proved that all his problems were over after …

Oslo, November 21st 2024: Lytix Biopharma refers to the release made today by its licensing partner Verrica Pharmaceuticals, announcing the pricing of a USD 42 million underwritten public offering. The offering is expected to close on November 22, 2024, and the gross proceeds from the offering are expected to be …